Business
Currency:USD
2019/FY
Stock NameRevenueRatio
Development and commercialization of innovative treatments for drug resistant bacterial infections37K100.00%
Region
Currency:USD
2019/FY
Stock NameRevenueRatio
U.S.37K100.00%